Wed, May 17|
Offloading DFUs: The Clinical Benefits of Early Intervention Using a Total Contact Cast System
Click to learn more!
Time & Location
May 17, 2023, 6:00 p.m. – 7:00 p.m. EDT
About the event
NSWOCC & WOC Institute Continuing Education Webinar: “Offloading DFUs: The Clinical Benefits of Early Intervention Using a Total Contact Cast System”
Diabetic foot ulcers (DFUs) remain one of the main complications associated with diabetes and patients do not always understand the seriousness of their condition. Without proper treatment, DFUs can become infected which may lead to serious complications from hospitalization to amputation, the latter being linked to a high mortality rate.
Please join Dr. Jeffrey Jensen for an in-depth presentation on current DFU statistics, the benefits of early intervention and the implementation of a prefabricated, easy-to-use Total Contact Cast (TCC) System that supports patient offloading compliance in a busy wound care practice. Dr. Jensen will also discuss how to effectively communicate the importance of seeking prompt medical attention when a patient is diagnosed with a DFU and how to manage patient expectations.
About Dr. Jeffrey Jensen
Jeffrey Jensen, DPM, FACFAS, is currently a Professor and the Director of the Arizona School of Podiatric Medicine at Midwestern University, Glendale, Arizona. He previously served as the Dean at the Barry University School of Podiatric Medicine from 2010-2014. As Dean, he founded the Paul & Margaret Brand Research Center in 2011.
From 1994-2010, Dr. Jensen was the clinic director of the Diabetic Foot & Wound Center in Denver, CO and served as the Externship and Research Director at the North Colorado Podiatric Surgical Residency from 2001-2010. He was an Assistant Clinical Professor at the University of Colorado Health Science Center from 1995-2010.
As an active researcher throughout his career, Dr. Jensen has generated over $5.0M in research grants from the National Institutes of Health, the Department of Defense and State organizations. This research has resulted in 10 patents for products addressing diabetic foot wounds, fractures and antimicrobials. His most recent research involves a Defense Advanced Research Projects Agency (DARPA) grant assessing gaseous Nitric Oxide under pressure as an antimicrobial for multidrug-resistant organisms.
In 2000, Dr. Jensen founded a medical device company, MedEfficiency, that created the “TCC-EZ” – a total contact casting system used to offload and assist in healing diabetic foot ulcers.
1. Articulate the clinical benefits of TCC as the gold standard and preferred method for offloading DFUs.
2. Review selected cases utilizing a prefabricated, easy-to-use TCC in the management and treatment of DFUs.
3. Discuss effective communication techniques on how to manage patient expectations.
4. Participate in a question-and-answer session.
Jeffrey Jensen, DPM, FACFAS
Director, Arizona School of Podiatric Medicine
In partnership with Integra Lifesciences